NCT00299884View on ClinicalTrials.gov

Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-lowering Strategy

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
DyslipidemiaVascular Disease
Interventions
DRUG

Lipitor 20 mg

A/A for 6 weeks

DRUG

Combination Ezetrol 10 mg and Lipidil Supra 160 mg

a/a for 6 weeks

Trial Locations (1)

K7L 5G2

Vascular Disease Prevention and Research Centre, Hotel Dieu Hospital, Kingston

All Listed Sponsors
lead

Queen's University

OTHER

NCT00299884 - Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-lowering Strategy | Biotech Hunter | Biotech Hunter